New MRI dye could sharpen images of damaged heart tissue in AFib patients
NCT ID NCT07083115
First seen Nov 17, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study aims to see if a newer MRI contrast agent (Gadopiclenol) can produce clearer images of heart damage in people with atrial fibrillation compared to standard contrast agents. About 50 adults with atrial fibrillation will receive a research MRI scan. The goal is to improve how doctors visualize and understand the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44106, United States
Conditions
Explore the condition pages connected to this study.